• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550400-08
Device Problems Inflation Problem (1310); Difficult or Delayed Activation (2577); Migration (4003)
Patient Problems Intimal Dissection (1333); Embolism (1829); Foreign Body In Patient (2687)
Event Date 11/03/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effects of dissection and embolism are listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported inflation issues; however, factors that may contribute to inflation issues include but are not limited to damage to the device, contamination in the inflation lumen, patient anatomical morphology, patient disease state, inflation technique, contrast dilution, and inadequate connection to the inflation device.The reported delayed activation appears to be related to operational circumstances as it is likely the inflation issue caused the delayed activation/wall apposition of the stent.During removal of the device it was noted that the stent had migrated and subsequent patient effects of dissection, embolism and foreign body in patient.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was performed to treat a lesion with heavy calcification, mild tortuosity and chronic total occlusion in the right circumflex coronary artery.A 4.00 x 8 mm xience sierra drug eluting stent delivery system (sds) was prepped outside the anatomy without any issues.The sds was advanced and the stent was attempted to be deployed; however, during deployment, it was suspected that the balloon was not fully inflated.This caused the stent to not fully appose to the arterial wall resulting in it moving freely within the vessel as witnessed on ivus.After the guide catheter [stent delivery system] was pulled back, the stent detached, and it was observed on imaging that the stent started to move distally.It was also noted that a dissection had occurred.The dissection was not treated.Since the stent was mobile, it was attempted to be tracked.However, the stent was unable to be found and remained in the patient.It was noted that the patient was stable and doing well.The procedure ended at this point.There was no reported delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10864887
MDR Text Key217097941
Report Number2024168-2020-09714
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227479
UDI-Public08717648227479
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/20/2021
Device Model Number1550400-08
Device Catalogue Number1550400-08
Device Lot Number0011541
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age67 YR
-
-